Case reports
Barath Jagadisan(King's College Hospital), Arvind Bagga(All India Institute of Medical Sciences), Renitha Raghavan(Jawaharlal Institute of Post Graduate Medical Education and Research), K. I. Arulselvi(Manipal Hospital), Sriram Krishnamurthy(Schrodinger (United States)), Pankaj Hari(Indian Council of Medical Research), Dhivyalakshmi Jeevarathnam(Manipal Hospital), Aditi Sinha, Shaila Bhattacharyya(Manipal Hospital), Priyanka Khandelwal(Chacha Nehru Bal Chikitsalaya), S. Deepak Barathi(Jawaharlal Institute of Post Graduate Medical Education and Research), R. Sreekar Kumar Reddy(Manipal Hospital)
Cited by 1
Related Papers
Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome
|Journal of the American Society of Nephrology|2004|415
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome
|Clinical Journal of the American Society of Nephrology|2010|203